ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

TMCI Treace Medical Concepts Inc

11.00
0.29 (2.71%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Treace Medical Concepts Inc TMCI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.29 2.71% 11.00 16:18:23
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.00 10.82 11.24 11.00 10.71
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202406:00GLOBETreace Medical Named First Medical Device Partner and..
17/4/202406:00GLOBETreace to Present at Bank of America Health Care Conference
16/4/202406:00GLOBETreace Announces First Annual National Bunion Day
09/4/202406:00GLOBETreace to Report First Quarter 2024 Financial Results
25/3/202406:00GLOBETreace Celebrates 100,000 Lapiplasty® 3D Bunion Correction®..
27/2/202415:13EDGAR2Form 8-K - Current report
27/2/202415:05GLOBETreace Medical Concepts Reports Fourth Quarter and Full-Year..
09/2/202416:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202415:05GLOBETreace to Report Fourth Quarter and Full-Year 2023 Financial..
02/2/202411:00GLOBETreace Announces Interim 3-Year ALIGN3D™ Clinical Study Data..
01/2/202406:00GLOBETreace to Highlight Latest Product Innovations and ALIGN3D™..
12/1/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:16EDGAR2Form 8-K - Current report
08/1/202406:00GLOBETreace Announces Preliminary, Unaudited Fourth Quarter and..
19/12/202306:00GLOBETreace to Present at 42nd Annual J.P. Morgan Healthcare..
09/11/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:07EDGAR2Form 8-K - Current report
09/11/202315:05GLOBETreace Medical Concepts Reports Third Quarter 2023 Financial..
03/11/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202306:00GLOBETreace to Present at Stifel 2023 Healthcare Conference
16/10/202306:00GLOBETreace to Report Third Quarter 2023 Financial Results
05/10/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202306:00GLOBETreace Highlights New Product Innovations and Updated..
14/9/202315:05GLOBETreace Medical Concepts Announces New Patent Covering..
11/9/202315:05GLOBETreace Medical Concepts Announces Limited Market Release of..
22/8/202315:05GLOBETreace Announces Participation in the 21st Annual Morgan..
21/8/202306:00GLOBETreace Medical Concepts Appoints Nathan Minnich as Senior..
09/8/202307:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:08EDGAR2Form 8-K - Current report
08/8/202315:05GLOBETreace Medical Concepts Reports Second Quarter 2023..
24/7/202315:05GLOBETreace Announces Participation in the UBS Medtech, Tools and..
18/7/202315:15GLOBETreace to Report Second Quarter 2023 Financial Results on..
12/7/202315:15GLOBETreace Appoints Julie Dewey as Chief Communications and..
13/6/202315:15GLOBETreace Medical Completes Acquisition of Technology Enabling..
01/6/202315:15GLOBETreace Medical Concepts to Acquire Technology Enabling..
08/5/202315:05GLOBETreace Medical Concepts Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock